SENSARS NEUROPROSTHETICS SARL

Their core work

SenSARS Neuroprosthetics is a Swiss SME that develops sensory feedback systems for limb prosthetics, enabling amputees to regain natural sensation during walking and movement. Their core technology involves nerve stimulation interfaces that restore tactile and proprioceptive feedback to prosthetic leg users. They have expanded from lower-limb prosthetics into broader neuroprosthetic applications, including vagal-cardiac interfaces for heart transplant patients, positioning them at the intersection of neural engineering and medical devices.

What they specialise in

How they've shifted over time

SenSARS began with focused feasibility work on restoring sensation for leg amputees (SENSY and SensAgain in 2017), essentially validating their core technology concept through SME Instrument Phase 1 and a smaller research grant. By 2019, they scaled significantly — GoSafe (EUR 1.6M) moved the walking-sensation technology toward market, while NeuHeart and NeuTouch broadened their neural interface expertise into cardiac medicine and robotic tactile sensing. The trajectory shows a company that proved a niche concept early, then both deepened it commercially and diversified the underlying technology platform.

SenSARS is expanding from limb prosthetics into a broader neuroprosthetics platform company, applying neural interface technology to cardiac and potentially other organ systems — making them increasingly relevant for any project involving bioelectronic medicine or closed-loop neural devices.

How they like to work

SenSARS predominantly leads its projects, coordinating 3 out of 5 H2020 engagements, which is unusual for an SME of this size — it signals strong initiative and the ability to manage EU consortia. With 20 unique partners across 9 countries, they build diverse teams rather than relying on a fixed circle. Their participation as a third party in NeuTouch (an MSCA training network) suggests they also contribute specialist expertise to larger academic-led efforts when the fit is right.

SenSARS has collaborated with 20 distinct partners across 9 countries, indicating a well-connected European network for a small company. Based in Lausanne (a major neuroscience hub near EPFL), they likely draw on strong Swiss and broader Western European academic and clinical partnerships.

What sets them apart

SenSARS occupies a rare niche: a private company focused specifically on restoring sensory feedback in prosthetics, not just motor function. Most prosthetics work targets movement; SenSARS targets what amputees feel, which is critical for natural gait and quality of life. Their Lausanne base places them in one of Europe's strongest neuroscience ecosystems, and their expansion into cardiac neuroprosthetics shows they can transfer their core neural interface technology across medical domains — a valuable trait for consortium builders looking for versatile neuroprosthetics partners.

Highlights from their portfolio

• GoSafe
  Their largest project (EUR 1.6M) and the culmination of their core mission — moving sensory prosthetics for natural walking from research toward a viable product.
• NeuHeart
  A strategic diversification into cardiac neuroprosthetics, demonstrating that their neural interface expertise extends well beyond limb prosthetics into bioelectronic medicine.
• NeuTouch
  An MSCA training network connecting prosthetics with robotics and computational neuroscience — shows SenSARS contributes to fundamental research, not just product development.